RU2140912C1 - Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения синтеза - Google Patents

Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения синтеза Download PDF

Info

Publication number
RU2140912C1
RU2140912C1 RU94036749A RU94036749A RU2140912C1 RU 2140912 C1 RU2140912 C1 RU 2140912C1 RU 94036749 A RU94036749 A RU 94036749A RU 94036749 A RU94036749 A RU 94036749A RU 2140912 C1 RU2140912 C1 RU 2140912C1
Authority
RU
Russia
Prior art keywords
formula
group
methyl
acid
carboxylic acid
Prior art date
Application number
RU94036749A
Other languages
English (en)
Russian (ru)
Other versions
RU94036749A (ru
Inventor
Лабеэв Бернар
Гюли Даниелл
Жанжан Франсис
Молимар Жан-Шарль
Буажгрэн Робер
Original Assignee
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи filed Critical Санофи
Publication of RU94036749A publication Critical patent/RU94036749A/ru
Application granted granted Critical
Publication of RU2140912C1 publication Critical patent/RU2140912C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
    • C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU94036749A 1993-10-12 1994-10-11 Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения синтеза RU2140912C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312136 1993-10-12
FR9312136A FR2711140B1 (fr) 1993-10-12 1993-10-12 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.

Publications (2)

Publication Number Publication Date
RU94036749A RU94036749A (ru) 1996-10-10
RU2140912C1 true RU2140912C1 (ru) 1999-11-10

Family

ID=9451754

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94036749A RU2140912C1 (ru) 1993-10-12 1994-10-11 Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения синтеза

Country Status (18)

Country Link
US (3) US5502059A (https=)
EP (1) EP0647629B1 (https=)
JP (1) JPH07278114A (https=)
KR (1) KR950011413A (https=)
CN (1) CN1108651A (https=)
AT (1) ATE181911T1 (https=)
AU (1) AU685154B2 (https=)
CA (1) CA2117821A1 (https=)
DE (1) DE69419377D1 (https=)
FI (1) FI944770A7 (https=)
FR (1) FR2711140B1 (https=)
HU (1) HUT70048A (https=)
IL (1) IL111239A0 (https=)
NO (1) NO304595B1 (https=)
NZ (1) NZ264661A (https=)
RU (1) RU2140912C1 (https=)
TW (1) TW300890B (https=)
ZA (1) ZA947957B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492411B1 (en) 1993-11-30 2002-12-10 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US6716991B1 (en) 1993-11-30 2004-04-06 G. D. Searle & Co. Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
FR2732967B1 (fr) * 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
FR2741621B1 (fr) * 1995-11-23 1998-02-13 Sanofi Sa Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2742148B1 (fr) * 1995-12-08 1999-10-22 Sanofi Sa Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
US6521561B1 (en) 1998-05-01 2003-02-18 President And Fellows Of Harvard College Main-group metal based asymmetric catalysts and applications thereof
IL142707A0 (en) 2000-04-27 2002-03-10 Pfizer Prod Inc Methods of treating obesity using a neurotensin receptor ligand
KR100425881B1 (ko) * 2001-03-14 2004-04-03 고광호 신규한 몰피난 유도체
CN1237119C (zh) * 2001-05-11 2006-01-18 三井化学株式会社 掺杂剂和含有其的导电聚合物材料
US6603000B2 (en) 2001-07-11 2003-08-05 Boehringer Ingelheim Pharmaceuticals, Inc. Synthesis for heteroarylamine compounds
EP1414800B1 (en) * 2001-07-11 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. A novel synthesis for heteroarylamine compounds
AR038967A1 (es) * 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
GB0323585D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
EP2368881A1 (en) * 2005-01-10 2011-09-28 University of Connecticut Heteropyrazole analogs acting on cannabinoid receptors
US7714014B2 (en) * 2005-12-09 2010-05-11 The Regents Of The University Of California Targeting GLI proteins in human cancer by small molecules
DK1988777T3 (da) 2006-02-09 2012-01-16 Athersys Inc Pyrazoler til behandling af fedme og andre cns-lidelser
EP2740726A1 (en) * 2012-12-07 2014-06-11 3B Pharmaceuticals GmbH Neurotensin receptor ligands
WO2015188073A1 (en) 2014-06-06 2015-12-10 Research Triangle Institute Apelin receptor (apj) agonists and uses thereof
CN108602806B (zh) 2015-12-09 2022-07-12 研究三角协会 改进的爱帕琳肽受体(apj)激动剂及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418845A1 (en) * 1989-09-22 1991-03-27 Fujisawa Pharmaceutical Co., Ltd. Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
EP0477049A1 (fr) * 1990-08-20 1992-03-25 Sanofi Dérivés d'amido-3 pyrazole, procédé pour leur préparation et compositions pharmaceutiques les contenant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US5288877A (en) * 1991-07-03 1994-02-22 Ppg Industries, Inc. Continuous process for preparing indolenine compounds
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418845A1 (en) * 1989-09-22 1991-03-27 Fujisawa Pharmaceutical Co., Ltd. Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
EP0477049A1 (fr) * 1990-08-20 1992-03-25 Sanofi Dérivés d'amido-3 pyrazole, procédé pour leur préparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2711140B1 (fr) 1996-01-05
KR950011413A (ko) 1995-05-15
HU9402933D0 (en) 1995-01-30
CN1108651A (zh) 1995-09-20
DE69419377D1 (de) 1999-08-12
CA2117821A1 (en) 1995-04-13
ATE181911T1 (de) 1999-07-15
NO943837L (no) 1995-04-18
NZ264661A (en) 1996-08-27
JPH07278114A (ja) 1995-10-24
US5585497A (en) 1996-12-17
US5502059A (en) 1996-03-26
NO304595B1 (no) 1999-01-18
US5523455A (en) 1996-06-04
FI944770L (fi) 1995-04-13
EP0647629A1 (fr) 1995-04-12
AU7575394A (en) 1995-05-04
TW300890B (https=) 1997-03-21
EP0647629B1 (fr) 1999-07-07
RU94036749A (ru) 1996-10-10
FI944770A7 (fi) 1995-04-13
NO943837D0 (no) 1994-10-11
FR2711140A1 (fr) 1995-04-21
IL111239A0 (en) 1994-12-29
AU685154B2 (en) 1998-01-15
HUT70048A (en) 1995-09-28
ZA947957B (en) 1995-05-22
FI944770A0 (fi) 1994-10-11

Similar Documents

Publication Publication Date Title
RU2140912C1 (ru) Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения синтеза
US7410984B2 (en) Compounds
US6384236B1 (en) N-(aroyl)glycine hydroxamic acid derivatives and related compounds
RU2690489C2 (ru) Ингибиторы лейкотриен а4-гидролазы
US7271289B2 (en) Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
JP4845733B2 (ja) Ｐ３８キナーゼ阻害剤としての３−アミノカルボニル、６−フェニル置換ピリジン−１−オキシド
TWI401248B (zh) Ｔｒｐ-ｐ８活性的小分子調節劑
US20030096737A1 (en) Caspase inhibitors and uses thereof
EP1097921A1 (fr) Phenylhydrazines
HUT68927A (en) Process for producing indoline derivatives and pharmaceutical compositions containing them
WO2003033496A1 (en) Beta-carbolin derivatives as ptp-inhibitors
JP2003503390A (ja) アゾリルベンズアミドおよびアナログならびに骨粗鬆症を治療するためのそれらの使用
WO2018153312A1 (zh) 氮杂螺环类化合物及其制备方法和应用
CN116018337A (zh) 铜绿假单胞菌毒力因子LasB抑制剂
US20070072901A1 (en) 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5
JP2005255675A (ja) 医薬組成物
BR0013750B1 (pt) Intermediários para a produção de derivados de ácido naftiridina-3-carboxílico
US5446065A (en) Sulfonamides of phenylalkylamines or phenoxyalkylamines processes for their preparation and medicaments containing these compounds
KR20220024051A (ko) 신규 아르기나제 억제제
WO2022149010A1 (en) Novel inhibitors of autotaxin
JPWO1995000502A1 (ja) 新規合成中間体およびアミノピペラジン誘導体の製造法
CN101252838A (zh) 新型含异羟肟酸的氨基酸衍生物
KR20050008664A (ko) 모폴린 유도체 및 이의 중간체의 제조를 위한 방법
KR890003357B1 (ko) 신규 티아졸 화합물의 제조방법
JPH0343272B2 (https=)